We recently had the pleasure of hosting an exclusive, focused roundtable discussion with the City Vet Clinic team, centered on the clinical value and real-world impact of Solensia, Librela, and Cytopoint from Zoetis.

This collaborative session brought together veterinary professionals for an in-depth exchange on how these innovative therapies are transforming the management of osteoarthritis and allergic dermatitis, helping improve comfort, mobility, and overall quality of life for companion animals.

---

Advancing Care Through Evidence-Based Innovation

During the discussion, participants explored how targeted biologic therapies can play a critical role in managing chronic pain and allergic conditions, offering new standards of care for long-term case management and patient wellbeing.

The session reinforced how precise, science-driven treatment approaches are not only supportive but often essential in enhancing treatment outcomes, daily function, and sustained quality of life for pets.

---

Strong Partnerships, Stronger Impact

Beyond clinical insights, the roundtable also highlighted the importance of collaboration between industry partners and veterinary practices in driving continuous improvement in standards of care.

Open dialogue, shared experiences, and practical perspectives created a productive environment where science met day-to-day clinical realities benefiting both patients and veterinary teams alike.

A sincere thank you to the City Vet Group for their active participation, valuable insights, and shared dedication to advancing veterinary medicine through innovation and evidence-based care. We look forward to many more meaningful collaborations ahead.